Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
SHANGHAI, April 1, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that results of its investigational drug...
Zeekr Group Announces March 2025 Delivery Update
HANGZHOU, China, April 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results for March 2025. In...
Blokees Officially Announces the Launch of the second season of 3rd BFC Creation Competition: Breaking the Cocoon Season
SHANGHAI, April 1, 2025 /PRNewswire/ -- On April 1st, the second season of the third BFC (Blokees Figures Creator) Creation Competition, themed "Breaking the Cocoon Season," was officially launched. This year's competition continues to adopt a...
Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research
Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aiming to accelerate personalized cancer care SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered...
China Renaissance Announces 2024 Annual Results: Strong Recovery Driven by Strategic Transformation
HONG KONG, March 31, 2025 /PRNewswire/ -- China Renaissance Holdings Limited ("China Renaissance" or the "Group", stock code: 1911.HK) today announced its annual results for the year ended December 31, 2024 (the "Reporting Period"). Despite a...
Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist
-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration. -As previously disclosed, oral tablet formulation...
Entrepreneur Universe Bright Group Announces Audited Financial Results for Fiscal Year Ended December 31, 2024
XI'AN, China, March 31, 2025 /PRNewswire/ -- Entrepreneur Universe Bright Group ("EUBG" or the "Company"), a Nevada corporation, today announced its audited financial results for the fiscal year ended December 31, 2024. The Company reported total...
SMARTIES™ 2025: Celebration of Marketing Excellence - Now Open for Submissions
SINGAPORE, March 31, 2025 /PRNewswire/ -- MMA Global proudly announces the opening of entries for the 2025 SMARTIES™ Awards, the premier marketing awards program that honors trailblazing brands, agencies, and marketers driving innovation and...
CNOOC Limited Announces A Hundred-Million-Ton Oilfield Discovery of Huizhou 19-6
HONG KONG, March 31, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that the Company has made a major oilfield discovery of Huizhou 19-6 in the deep and ultra-deep...
Fosun International Announces 2024 Annual Results: Total Revenue Reaches RMB192.14 Billion, Industrial Operation Profit Amounts to RMB4.9 Billion, Overall Operational Fundamentals Remain Stable
2024 Annual Results Highlights: Total revenue reached RMB192.14 billion; Industrial operation profit amounted to RMB4.9 billion; Total revenue generated by the four core subsidiaries amounted to RMB134.65 billion, accounting for 70.1% of the Group's...